Aligos Therapeutics, Inc.

Q1 2026 13F Holders

Symbol
ALGS
CUSIP
01626L105
Type
Equity
Class
COM
Num filings
1
Total reported value, excl. options
$505.00
Manager Report Date Value ($000) Shares Option Type